These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26527781)

  • 21. [Anti progestins].
    Fujimoto J
    Nihon Rinsho; 2006 Apr; 64 Suppl 4():447-51. PubMed ID: 16689349
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of the antiprogesterone RU-38486 on meningioma implanted into nude mice.
    Olson JJ; Beck DW; Schlechte JA; Loh PM
    J Neurosurg; 1987 Apr; 66(4):584-7. PubMed ID: 3559725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrent meningioma: salvage therapy with long-acting somatostatin analogue.
    Chamberlain MC; Glantz MJ; Fadul CE
    Neurology; 2007 Sep; 69(10):969-73. PubMed ID: 17785665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression.
    DeBattista C; Belanoff J; Glass S; Khan A; Horne RL; Blasey C; Carpenter LL; Alva G
    Biol Psychiatry; 2006 Dec; 60(12):1343-9. PubMed ID: 16889757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium channel antagonists augment hydroxyurea- and ru486-induced inhibition of meningioma growth in vivo and in vitro.
    Ragel BT; Gillespie DL; Kushnir V; Polevaya N; Kelly D; Jensen RL
    Neurosurgery; 2006 Nov; 59(5):1109-20; discussion 1120-1. PubMed ID: 17143245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcoma.
    Ramondetta LM; Johnson AJ; Sun CC; Atkinson N; Smith JA; Jung MS; Broaddus R; Iyer RB; Burke T
    Cancer; 2009 May; 115(9):1867-74. PubMed ID: 19241422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma.
    Mason WP; Gentili F; Macdonald DR; Hariharan S; Cruz CR; Abrey LE
    J Neurosurg; 2002 Aug; 97(2):341-6. PubMed ID: 12186462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of Mifepristone in Meningiomas Management: A Systematic Review of the Literature.
    Cossu G; Levivier M; Daniel RT; Messerer M
    Biomed Res Int; 2015; 2015():267831. PubMed ID: 26146614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydroxyurea chemotherapy for unresectable or residual meningioma.
    Newton HB; Slivka MA; Stevens C
    J Neurooncol; 2000 Sep; 49(2):165-70. PubMed ID: 11206012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of labor with mifepristone--a randomized, double-blind study versus placebo.
    Stenlund PM; Ekman G; Aedo AR; Bygdeman M
    Acta Obstet Gynecol Scand; 1999 Oct; 78(9):793-8. PubMed ID: 10535343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mifepristone. Auxiliary therapeutic use in cancer and related disorders.
    Koide SS
    J Reprod Med; 1998 Jul; 43(7):551-60. PubMed ID: 9693404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydroxyurea chemotherapy for meningiomas: enlarged cohort with extended follow-up.
    Newton HB; Scott SR; Volpi C
    Br J Neurosurg; 2004 Oct; 18(5):495-9. PubMed ID: 15799152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mifepristone as treatment of recurrent progesterone receptor-positive uterine leiomyosarcoma.
    Koivisto-Korander R; Leminen A; Heikinheimo O
    Obstet Gynecol; 2007 Feb; 109(2 Pt2):512-4. PubMed ID: 17267877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Endocrine treatment of meningiomas: a review].
    da Motta LA; da Motta LD
    Arq Neuropsiquiatr; 1995 Jun; 53(2):324-32. PubMed ID: 7487548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential Tumor Progression Patterns in Skull Base Versus Non-Skull Base Meningiomas: A Critical Analysis from a Long-Term Follow-Up Study and Review of Literature.
    Savardekar AR; Patra DP; Bir S; Thakur JD; Mohammed N; Bollam P; Georgescu MM; Nanda A
    World Neurosurg; 2018 Apr; 112():e74-e83. PubMed ID: 29258946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sunitinib for atypical and anaplastic meningioma.
    Rahman A
    Lancet Oncol; 2014 Sep; 15(10):e424. PubMed ID: 25328951
    [No Abstract]   [Full Text] [Related]  

  • 37. Lack of efficacy of megestrol acetate in the treatment of unresectable meningioma.
    Grunberg SM; Weiss MH
    J Neurooncol; 1990 Feb; 8(1):61-5. PubMed ID: 2319292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid reversal of psychotic depression using mifepristone.
    Belanoff JK; Flores BH; Kalezhan M; Sund B; Schatzberg AF
    J Clin Psychopharmacol; 2001 Oct; 21(5):516-21. PubMed ID: 11593077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meningioma and hormonal influences.
    Wahab M; Al-Azzawi F
    Climacteric; 2003 Dec; 6(4):285-92. PubMed ID: 15006250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Oncological and endocrine administration of the antiprogestagen RU 486].
    Lamberts SW
    Ned Tijdschr Geneeskd; 1990 Dec; 134(52):2521-4. PubMed ID: 2270126
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.